News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Durham firm with innovative brain cancer treatment lights up $642K equity round


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 I did not see research results but the methodology looks very interesting


Posted on: 05/03/2018

Durham firm with innovative brain cancer treatment lights up $642K equity round

 https://www.wraltechwire.com/2018/05/02/durham-firm-with-innovative-brain-cancer-treatment-lights-up-642k-equity-round/




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740